Our PCR results showed that tRF5-GluCTC is highly dysregulated in TAO patients and probably plays a regulatory role through the verified differentially expressed target mRNAs ATF3, HSD17B2 and PMAIP1. This evidence concerns the gene HSD17B2 and thromboangiitis obliterans.